Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis
Qingxin Mu(St. Jude Children's Research Hospital), Rodney J. Y. Ho(University of Washington), Linxi Zhu(Wenzhou University), Jesse Yu(University of Washington), James I. Griffin(University of Washington), Lisa A. McConnachie(University of Washington), Yan Wu(Shanghai Jiao Tong University)
Cited by 13
Related Papers
Abscisic Acid Signaling Through Cyclic ADP-Ribose in Plants
|Science|1997|420
Size-Dependent Cell Uptake of Protein-Coated Graphene Oxide Nanosheets
|ACS Applied Materials & Interfaces|2012|364
Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response
|Pharmacology & Therapeutics|2022|99
PLGA-PEG-PLGA triblock copolymeric micelles as oral drug delivery system: In vitro drug release and in vivo pharmacokinetics assessment
|Journal of Colloid and Interface Science|2016|84